National Health Investors, Inc. (NHI)
NYSE: NHI · Real-Time Price · USD
76.37
+0.63 (0.83%)
At close: Dec 31, 2025, 4:00 PM EST
76.75
+0.38 (0.50%)
After-hours: Dec 31, 2025, 7:35 PM EST
National Health Investors Stock Forecast
Stock Price Forecast
The 5 analysts that cover National Health Investors stock have a consensus rating of "Buy" and an average price target of $85.2, which forecasts a 11.56% increase in the stock price over the next year. The lowest target is $80 and the highest is $90.
Price Target: $85.2 (+11.56%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for National Health Investors stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Hold | 2 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 4 | 4 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $81 → $83 | Strong Buy | Maintains | $81 → $83 | +8.68% | Dec 16, 2025 |
| Keybanc | Keybanc | Buy Maintains $80 → $88 | Buy | Maintains | $80 → $88 | +15.23% | Dec 4, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $80 → $85 | Hold | Maintains | $80 → $85 | +11.30% | Nov 25, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $90 | Buy | Initiates | $90 | +17.85% | Oct 1, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $76 → $80 | Hold | Maintains | $76 → $80 | +4.75% | Aug 27, 2025 |
Financial Forecast
Revenue This Year
358.68M
from 335.58M
Increased by 6.88%
Revenue Next Year
400.91M
from 358.68M
Increased by 11.77%
EPS This Year
3.08
from 3.13
Decreased by -1.66%
EPS Next Year
3.31
from 3.08
Increased by 7.55%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 387.7M | 453.4M | ||||
| Avg | 358.7M | 400.9M | ||||
| Low | 325.2M | 361.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 15.5% | 26.4% | ||||
| Avg | 6.9% | 11.8% | ||||
| Low | -3.1% | 0.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 3.36 | 3.58 | |
| Avg | 3.08 | 3.31 | |
| Low | 2.78 | 3.16 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 7.3% | 16.3% | |
| Avg | -1.7% | 7.5% | |
| Low | -11.1% | 2.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.